GR1010656B - Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents

Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου Download PDF

Info

Publication number
GR1010656B
GR1010656B GR20230100243A GR20230100243A GR1010656B GR 1010656 B GR1010656 B GR 1010656B GR 20230100243 A GR20230100243 A GR 20230100243A GR 20230100243 A GR20230100243 A GR 20230100243A GR 1010656 B GR1010656 B GR 1010656B
Authority
GR
Greece
Prior art keywords
atypical antipsychotic
antipsychotic agent
prepatation
pharmaceutical composition
relates
Prior art date
Application number
GR20230100243A
Other languages
English (en)
Inventor
Ευαγγελος Ανδρεα Καραβας
Original Assignee
Φαρματεν Α.Β.Ε.Ε.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Α.Β.Ε.Ε., filed Critical Φαρματεν Α.Β.Ε.Ε.,
Priority to GR20230100243A priority Critical patent/GR1010656B/el
Publication of GR1010656B publication Critical patent/GR1010656B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά φαρμακευτικά σκευάσματα ελεγχόμενης αποδέσμευσης αποτελούμενα από έναν άτυπο αντιψυχωσικό παράγοντα, όπως Αριπιπραζόλη ή κάποιο φαρμακευτικά αποδεκτό άλας αυτής, τα οποία σχηματίζουν δεξαμενή που παρέχει παρατεταμένη αποδέσμευση του φαρμάκου. Η εφεύρεση αφορά επίσης τη μέθοδο παρασκευής του ως άνω σκευάσματος.
GR20230100243A 2023-03-23 2023-03-23 Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου GR1010656B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20230100243A GR1010656B (el) 2023-03-23 2023-03-23 Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20230100243A GR1010656B (el) 2023-03-23 2023-03-23 Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
GR1010656B true GR1010656B (el) 2024-03-21

Family

ID=90823022

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20230100243A GR1010656B (el) 2023-03-23 2023-03-23 Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Country Status (1)

Country Link
GR (1) GR1010656B (el)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1675573B1 (en) * 2003-10-23 2008-10-22 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile injectable aripiprazole formulation and method
EP2717859B1 (en) * 2011-06-07 2016-08-31 Otsuka Pharmaceutical Co., Ltd. Freeze-dried aripiprazole formulation
EP4043008A1 (en) * 2021-02-15 2022-08-17 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Method for the preparation of a pharmaceutical composition comprising aripiprazole

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1675573B1 (en) * 2003-10-23 2008-10-22 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile injectable aripiprazole formulation and method
EP2717859B1 (en) * 2011-06-07 2016-08-31 Otsuka Pharmaceutical Co., Ltd. Freeze-dried aripiprazole formulation
EP4043008A1 (en) * 2021-02-15 2022-08-17 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Method for the preparation of a pharmaceutical composition comprising aripiprazole

Similar Documents

Publication Publication Date Title
MX2017010477A (es) Compuestos triciclicos y usos de los mismos en medicina.
MX2020000268A (es) Agonista de fxr.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
SG11202106160WA (en) Pharmaceutical composition for prevention or treatment of cancer comprising weissella cibaria wikim28 as active ingredient
MX2018002627A (es) Metodo de cristalizacion y biodisponibilidad.
EA033396B1 (ru) Быстродействующие инсулиновые композиции
WO2019035057A3 (en) EXOSOMES FOR TARGET-SPECIFIC DELIVERY AND METHODS OF PREPARATION AND ADMINISTRATION THEREOF
EA038828B9 (ru) Фармацевтическая композиция, содержащая действенный ингибитор urat1
WO2019168688A3 (en) Quinolone analogs and their salts, compositions, and method for their use
PH12019500731A1 (en) Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
MX2020013694A (es) Compuestos heterocíclicos como inhibidores de trk.
PT3604304T (pt) Composto derivado de pirrolo-piridina, método para a sua preparação e composição farmacêutica que o contém como substância ativa para prevenção ou tratamento de doenças relacionadas com proteína quinase
EP4252856A3 (en) Novel quinazolinones that inhibit the formation of tau oligomers and their method of use
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
MX2021009539A (es) Derivado del profarmaco 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y aplicacion del mismo en medicina.
MX2023006504A (es) Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo.
MX2023003230A (es) Procesos e intermediario para la preparacion a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbon il)-piridin-2-il]-benzamida y preparacion de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il ]-benzamida.
MX2021004551A (es) Composicion farmaceutica para el tratamiento de la anemia aplasica.
GR1010656B (el) Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
ZA202304201B (en) Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
MX2018011696A (es) Composición farmacéutica de dapagliflozina.
ZA202304200B (en) Pharmaceutical composition comprising aripiprazole and method for the preparation thereof
GR1010624B (el) Φαρμακευτικο σκευασμα που περιλαμβανει αριπιπραζολη και μεθοδος για την παρασκευη αυτου
CR20220667A (es) Derivados de tetrazol como inhibidores de trpa1
MX2019003365A (es) Composiciones de ester de colina de acido lipoico y metodos para estabilizar en productos farmacologicos farmaceuticamente relevantes.

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20240410